Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfar S Azmi

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Seminars in Cancer Biology|April 15, 2015
Therapeutic targeting of replicative immortalityPaul Yaswen, Karen L MacKenzie, W Nicol Keith, et al.
JCO Oncology Advances|May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT AlterationsIbrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable PathwaysMd Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, et al.
Seminars in Cancer Biology|April 14, 2015
Cancer prevention and therapy through the modulation of the tumor microenvironmentStephanie C Casey, Amedeo Amedei, Katia Aquilano, et al.
Seminars in Cancer Biology|January 21, 2015
Broad targeting of angiogenesis for cancer prevention and therapyZongwei Wang, Charlotta Dabrosin, Xin Yin, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinomaHusain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Seminars in Cancer Biology|April 15, 2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutritionLynnette R Ferguson, Helen Chen, Andrew R Collins, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Seminars in Cancer Biology|April 15, 2015
Therapeutic targeting of replicative immortalityPaul Yaswen, Karen L MacKenzie, W Nicol Keith, et al.
JCO Oncology Advances|May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT AlterationsIbrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable PathwaysMd Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, et al.
Seminars in Cancer Biology|April 14, 2015
Cancer prevention and therapy through the modulation of the tumor microenvironmentStephanie C Casey, Amedeo Amedei, Katia Aquilano, et al.
Seminars in Cancer Biology|January 21, 2015
Broad targeting of angiogenesis for cancer prevention and therapyZongwei Wang, Charlotta Dabrosin, Xin Yin, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinomaHusain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Seminars in Cancer Biology|April 15, 2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutritionLynnette R Ferguson, Helen Chen, Andrew R Collins, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Pageof 16